Abstract
Prostate cancer is one of the most common male malignant tumors in Western countries. In the United States, there are about 170,000 new cases of prostate cancer in 2019, ranking second only to lung cancer.1, 2 In recent years, the incidence of prostate cancer in China is gradually increasing occupying the third place among male urogenital malignancies. The metastasis of prostate cancer mainly depends on blood vessels and lymphatic vessels, and the late discovery and poor prognosis of patients are the main reasons for the high fatality rate.2 Relevant epidemiological studies on immigration have found that the incidence of PCa in The Asian population in the United States is as high as 77.8 / l0000, which is similar to local residents and significantly higher than that in the native population in Asia. This suggests that, in addition to race and family history, different diet and lifestyle in China and the West may play an important role in the development and progression of PCa.3 Epidemiological studies have shown an association between geographic location and prostate cancer risk. In fact, the incidence of prostate cancer in Western men is 15 times higher than in Asian men. This suggests that environmental factors or lifestyle, especially diet and nutrition, may play a key role in the occurrence and development of prostate cancer.4 To some extent, metabolic syndrome reflects the diet and lifestyle of patients and is closely related to the occurrence and development of prostate cancer. In addition, Vascular endothelial growth factor (VEGF) as a kind of multi functional cytokine works through specific role in endothelial cells.It can promote endothelial cell proliferation, migration, and increase Vascular permeability. And VEGF can be induced in the body for blood vessel growth, angiogenesis, is closely related to tumorigenesis and metastasis. Numerous recent studies have shown that VEGF is closely related to the occurrence and development of prostate cancer and metabolic syndrome.5 In this paper, multiple physiological and pathological mechanisms of VEGF and metabolic syndrome associated with prostate cancer are reviewed.
Highlights
Prostate cancer is one of the most common male malignant tumors in Western countries
The metastasis of prostate cancer mainly depends on blood vessels and lymphatic vessels, and the late discovery and poor prognosis of patients are the main reasons for the high fatality rate.[2]
Studies have found that Vascular endothelial growth factor (VEGF) in prostate cancer patients is highly expressed and positively correlated with microvascular density, which is closely correlated with tumor metastasis.[21]
Summary
VEGF is a pluripotent cytokine that is expressed in many normal tissues of humans and animals. VEGF is secreted by endothelial cells, smooth muscle cells and stromal cells. It can be tested with different methods like Northren blot, PTPCR, immunohistochemistry and immunofluore scence method. VEGF can be produced and secreted by epithelial cells and smooth muscle cells, and is often at a higher level in tissues during the growth and development of blood vessels. High expression of VEGF is seen in tumor, fibroma, delayed allergic reaction, hypoxia and other pathological conditions. VEGF can act on vascular endothelial cells and have a variety of physiological functions
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
